http://ift.tt/eA8V8J
TOKYO & LONDON–(BUSINESS WIRE)–Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) and MiNA Therapeutics Limited (“MiNA”) announced today that the companies have entered into a definitive agreement under which Sosei will make an investment in and acquire an exclusive option to potentially acquire MiNA Therapeutics, a private UK biopharmaceutical company and pioneer in RNA activation therapeutics (small activating RNAs, saRNAs). Key aspects of the agreement include: Sosei will make an
May 03, 2017 at 07:30AM
from
No comments:
Post a Comment